Antibiotic resistance is an urgent problem globally when treating many infections, and scientists continue to search for new ways to combat resistance. Now a team of scientists led by David Thanassi, PhD, Chair of the Department of Molecular Genetics and Microbiology at Stony Brook University, believe a better understanding of the mechanisms of pili, the hair-like surface appendages on bacteria that initiate infection, could hold a key to developing new and more effective therapeutics.
In a paper published in Nature, Thanassi and colleagues used an advanced imaging technique called cryo-electron microscopy to examine pili assembled by uropathogenic strains of Escherichia coli, the major causative agent of urinary tract infections. Their imaging captured a previously unrecognized stage in the pilus assembly process.
“This discovery provides us with new insights into the mechanism by which bacteria build these essential virulence structures leading to infection,” says Thanassi, who emphasizes that antibiotic resistance rates have risen to alarming levels, jeopardizing the effective treatment of even common infections such as of the urinary tract. “Our findings open the door to new therapies targeting bacterial pili, and related virulence factors, as an alternative to traditional antibiotics.”
The research is supported in part by a grant from the National Institutes of Health’s National Institute of General Medical Sciences.
Source: Stony Brook University
Reflecting on the US Withdrawal from the World Health Organization
January 21st 2025An infection preventionist reels from the US exit from WHO, writing that it disrupts global health efforts, weakens infection control, and lacks research funding and support for low-income nations dependent on WHO for health care resources.
Infections Do Not Recognize International Borders: The Potential Impact of US Withdrawal From WHO
January 21st 2025The US withdrawal from WHO jeopardizes infection prevention, research funding, and global collaboration, disproportionately impacting low-income nations reliant on WHO support for equitable health care advancements.
Infection Intel:EvaClean Expands Global Reach With Microsplitting Partnership
January 20th 2025EvaClean partners with Microsplitting Ltd. to distribute its advanced disinfection systems and absorbents, revolutionizing infection prevention across health care, education, hospitality, and industrial sectors worldwide.